RedHill Biopharma Provides Update on Opaganib (Yeliva®)

    NEXT STORY
    LexaGene Provides Corporate Update
    PREV STORY
    Teleflex Celebrates 175,000 Patients Treated with the UroLift® System
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OncoImmunology Publishes Pre-clinical Research Showing Galectin Therapeutics’ Belapectin Galectin-3 Inhibitor Reduces Tumor Progression in Combination with Anti-OX40 Therapy

    author_avatar
    NASDAQ Market News

    MPI – Publication of Merger Prospectus

    author_avatar
    NASDAQ Market News

    Inventiva – New promising results on lanifibranor to be presented at The Liver Meeting® 2019

    author_avatar
    NASDAQ Market News